RC
WST icon

RegentAtlantic Capital’s West Pharmaceutical WST Stock Holding History

RegentAtlantic Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$276K Buy
+1,118
New +$341K 0.01% 576
2022
Q2 		– Sell
-857
Closed -$352K – 714
2022
Q1 		$352K Buy
857
+291
+51% +$114K 0.01% 538
2021
Q4 		$265K Buy
+566
New +$244K 0.01% 602

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RegentAtlantic Capital's WST Position: Q3 2022 in Review

RegentAtlantic Capital opened a new position in West Pharmaceutical (WST) in Q3 2022: 1,118 shares worth $276K. The stake represents 0.01% of the portfolio and ranks #576 among its holdings. This is a return to the name: RegentAtlantic Capital previously reported a position in WST as recently as Q1 2022.

RegentAtlantic Capital first reported a position in WST in Q4 2021 and has held it in 3 quarters since. The position peaked at $352K in Q1 2022. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • RegentAtlantic Capital held 1,118 shares of West Pharmaceutical worth $276K as of Q3 2022.
  • West Pharmaceutical was a new RegentAtlantic Capital position in Q3 2022.
  • West Pharmaceutical made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #576 holding.
  • RegentAtlantic Capital first reported a position in West Pharmaceutical in Q4 2021 and has held it in 3 quarters since.
  • RegentAtlantic Capital's West Pharmaceutical position peaked at $352K in Q1 2022.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.